Unknown PHASE3 INTERVENTIONAL 2-arm NCT02002247

SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial). (SUSTAINCSX)

SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial). A Multicentre Randomized Controlled Trial of High Dose Sodium-selenite Administration in High Risk Cardiac Surgical Patients

Sponsor: Daren K. Heyland

Conditions Heart Disease

Interventions Placebo sodium selenite

Updated 13 times since 2017 Last updated: May 27, 2021 Started: Jan 31, 2015 Primary completion: Feb 28, 2021 Completion: Jul 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02002247, this PHASE3 trial focuses on Heart Disease and remains ongoing. Sponsored by Daren K. Heyland, it has been updated 13 times since 2015, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

13 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Jun 2025 — Sep 2025 [monthly]

Unknown PHASE3
Apr 2025 — Jun 2025 [monthly]

Unknown PHASE3
Sep 2024 — Apr 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown

▶ Show 8 earlier versions

Jun 2023 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Sep 2021 — Jun 2023 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE3
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE3
Oct 2018 — Feb 2020 [monthly]

Recruiting PHASE3
Jun 2018 — Oct 2018 [monthly]

Recruiting PHASE3
Jul 2017 — Jun 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Jul 2017 [monthly]

Recruiting PHASE3

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daren K. Heyland
Queen's University
RWTH Aachen University
biosyn Arzneimittel GmbH

Data source: Clinical Evaluation Research Unit at Kingston General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Bonn, Germany , Cologne, Germany , Frankfurt, Germany , Freiburg im Breisgau, Germany , Giessen, Germany , Hamilton, Canada , Kiel, Germany , London, Canada , Mainz, Germany and 8 more locations